Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,725 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PET-adapted therapy after three cycles of ABVD for all stages of Hodgkin lymphoma: results of the GATLA LH-05 trial.
Pavlovsky A, Fernandez I, Kurgansky N, Prates V, Zoppegno L, Negri P, Milone G, Cerutti I, Zabaljauregui S, Mariano R, Grecco HF, Basquiera AL, Saba S, Rudoy S, Sackmann F, Castano V, Remaggi G, Cabrejo M, Roveri E, Casale MF, Cabane V, Taus R, Venturini C, Sakamoto F, Varela AI, Riddick M, Pavlovsky S; Grupo Argentino de tratamiento de Leucemia Aguda (GATLA), Argentina. Pavlovsky A, et al. Among authors: fernandez i. Br J Haematol. 2019 Jun;185(5):865-873. doi: 10.1111/bjh.15838. Epub 2019 Mar 12. Br J Haematol. 2019. PMID: 30864146 Free article.
A randomized study of mitoxantrone plus cytarabine versus daunomycin plus cytarabine in the treatment of previously untreated adult patients with acute nonlymphocytic leukemia.
Pavlovsky S, Gonzalez Llaven J, Garcia Martinez MA, Sobrevilla P, Eppinger-Helft M, Marin A, López-Hernández M, Fernandez I, Rubio ME, Ibarra S, et al. Pavlovsky S, et al. Among authors: fernandez i. Ann Hematol. 1994 Jul;69(1):11-5. doi: 10.1007/BF01757342. Ann Hematol. 1994. PMID: 8061102 Clinical Trial.
Multivariate analyses of prognostic factors associated with hematopoietic recovery in autograft patients with different sources of progenitor cells. A GATMO experience. Argintine Group of Bone Marrow Transplant.
Pavlovsky S, Koziner B, Milone G, Lastiri F, Bayo R, Fernández I, Dengra C, Martinez Rolón J, Feldman L, Kusminsky G, Corrado C, Bullorsky E, Milone J, Garcia JJ, Cerutti I, Saporito G, Robinson A, Canepa C. Pavlovsky S, et al. Among authors: fernandez i. Ann Oncol. 1996 Sep;7(7):719-24. doi: 10.1093/oxfordjournals.annonc.a010721. Ann Oncol. 1996. PMID: 8905030 Free article. Clinical Trial.
1,725 results